<DOC>
	<DOC>NCT02049424</DOC>
	<brief_summary>Outcome evaluation in patients who underwent transplantation with T-repleted bone marrow after post-transplantation cyclophosphamide</brief_summary>
	<brief_title>Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow</brief_title>
	<detailed_description>Patients who underwent transplantation with T-repleted bone marrow haploidentical transplantation will be analyzed considering toxicity incidence (GVHD, infective complications, graft-failure incidence and TRM)and efficacy variables (Overall Survival, Progression Free Survival and Relapse incidence)</detailed_description>
	<criteria>patients affected by hematologic neoplasia who underwent a haploidentical transplantation (23 mismatches) from a familiar donor, with nonex vivo manipulated bone marrow and posttransplantation cyclophosphamide ex vivo manipulated bone marrow transplantation use of antilymphocyte serum during conditioning</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>